SCHEMBL7978729

SCHEMBL7978729

CCOc1cc(OC)c(C(=O)Nc2cccc3c2CCNC3C)cc1Cl

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.45
ALDH1A1 P00352 3/20 0.45
KMT2A Q03164 1/20 0.45
LMNA P02545 2/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
NPC1 O15118 2/20 0.41
ATM Q13315 2/20 0.41
POLB P06746 2/20 0.41
CASP3 P42574 1/20 0.41
SENP8 Q96LD8 1/20 0.41
SENP7 Q9BQF6 1/20 0.41
SENP6 Q9GZR1 1/20 0.41
IRAK4 Q9NWZ3 1/20 0.41
TP53 P04637 1/20 0.41
MITF O75030 1/20 0.40
RAB9A P51151 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
MAPT P10636 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7993464 0.84 KMT2A (0.42) KDM4EALDH1A1KMT2ALMNANPC1
SCHEMBL7797913 0.78 CYP3A4 (0.40) KDM4EALDH1A1KMT2ALMNACYP3A4
SCHEMBL8025984 0.78 MRGPRX1 (0.41) KDM4EALDH1A1KMT2ALMNANPC1
SCHEMBL8183726 0.76 KMT2A (0.44) KDM4EALDH1A1KMT2ANPC1ATM
SCHEMBL8077366 0.74 RXFP1 (0.40) ALDH1A1CYP3A4NPC1POLBRAB9A
SCHEMBL8185203 0.73 KMT2A (0.48) KDM4EALDH1A1KMT2ALMNANPC1
SCHEMBL7991365 0.73 BRPF1 (0.43) KDM4EALDH1A1KMT2ALMNACYP2C9
SCHEMBL8444379 0.71 MAPT (0.46) KDM4EALDH1A1KMT2ALMNANPC1
SCHEMBL1010394 0.70 ADRA2A (0.49) KDM4EALDH1A1NPC1CASP3RAB9A
SCHEMBL8187672 0.69 ALDH1A1 (0.50) KDM4EALDH1A1KMT2ALMNANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6277861-B1 FOR TREATMENT AND PROPHYLAXIS OF NERVOUS SYSTEM DISORDERS, PSYCHOLOGICAL DISORDERS, MUSCULAR DISORDERS, DRUG ADDICTION WITHDRAWAL, PAIN SMITHKLINE BEECHAM, P.L.C. (GB) 2001-08-21 US disclosed
EP-0971897-A1 ANTI-CONVULSANT ISOQUINOLYL-BENZAMIDE DERIVATIVES SMITHKLINE BEECHAM PLC (GB) 2000-01-19 EP disclosed
WO-1998041507-A1 ANTI-CONVULSANT ISOQUINOLYL-BENZAMIDE DERIVATIVES SMITHKLINE BEECHAM PLC (GB) 1998-09-24 WO disclosed